title: Renal function in patients receiving tenofovir with ritonavir/lopinavir or ritonavir/atazanavir in the HIV Outpatient Study (HOPS) cohort.
authors.forename: Kate
authors.initials: K
authors.lastname: Buchacz
authors.forename: Benjamin
authors.initials: B
authors.lastname: Young
authors.forename: Rose K
authors.initials: RK
authors.lastname: Baker
authors.forename: Anne
authors.initials: A
authors.lastname: Moorman
authors.forename: Joan S
authors.initials: JS
authors.lastname: Chmiel
authors.forename: Kathy C
authors.initials: KC
authors.lastname: Wood
authors.forename: John T
authors.initials: JT
authors.lastname: Brooks
mesh_terms: D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000328:Adult; D000069446:Atazanavir Sulfate; D015331:Cohort Studies; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007668:Kidney / Q000187:drug effects*; D061466:Lopinavir; D008297:Male; D009842:Oligopeptides / Q000009:adverse effects* / Q000627:therapeutic use; D063065:Organophosphonates / Q000009:adverse effects* / Q000627:therapeutic use; D011725:Pyridines / Q000009:adverse effects* / Q000627:therapeutic use; D011744:Pyrimidinones / Q000009:adverse effects* / Q000627:therapeutic use; D019438:Ritonavir / Q000009:adverse effects* / Q000627:therapeutic use; D000068698:Tenofovir
chemical_list: D009842:Oligopeptides; D063065:Organophosphonates; D011725:Pyridines; D011744:Pyrimidinones; D061466:Lopinavir; D000069446:Atazanavir Sulfate; D000068698:Tenofovir; D000225:Adenine; D019438:Ritonavir